EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Immunological and Metabolic Associations of Latent Tuberculosis Infection in Type 2 Diabetes Mellitus: A Meta-Analysis of HbA1c Levels and IFN-γ Responses

Muhammad Zaky Innanda, Dewi Wahyu Fitrina, Aisyah Elliyanti

Molecular and Cellular Biomedical Sciences · 2026-11-02 · 10 (3) · 131

DOI: 10.21705/mcbs.v10i3.795 ↗
AbstractBibliografische Angaben

Abstract

The intersection of tuberculosis (TB) and type 2 diabetes mellitus (T2DM) represents a major global health challenge. Although T2DM is a recognized risk factor for active TB, its epidemiological impact on latent tuberculosis infection (LTBI) and the underlying immune mechanisms remain unclear. This meta-analysis estimated the global prevalence of LTBI in T2DM, compared LTBI risk with non-diabetic controls, and evaluated the roles of glycated hemoglobin (HbA1c) and interferon-gamma (IFN-γ) in immune dysregulation. HbA1c and IFN-γ were selected because they represent the gold-standard indicators of long-term glycemic control and IGRA-based immune responses, respectively. A systematic search identified observational studies using interferon-gamma release assays (IGRA) to diagnose LTBI in T2DM patients. Random-effects meta-analysis with restricted maximum-likelihood estimation was performed to calculate pooled prevalence, odds ratios (ORs), mean differences (MDs) for HbA1c, and standardized mean differences (SMDs) for IFN-γ levels. Ten studies involving 1,740 T2DM patients and non-diabetic controls were included. The pooled LTBI prevalence in T2DM was 27% (95% CI: 23%–32%; I² = 76%). Compared with non-diabetic individuals, T2DM patients had an 86% higher risk of LTBI (OR 1.86; 95% CI: 1.41–2.45; p

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →